Featured Topics
New Era of Smarter Food Safety
A new approach to food safety that recognizes and builds on the progress made in the past but looks towards what processes and tools will be needed for the future.
Fostering Drug Competition
Increasing the availability of generic drugs helps to create competition in the marketplace, helping make treatment more affordable and increasing access to healthcare for more patients.
Combating the Opioid Crisis
FDA takes actions to combat prescription opioid abuse.
Recalls, Market Withdrawals, & Safety Alerts
The FDA provides information gathered from press releases and other public notices about certain recalls of FDA-regulated products. Not all recalls have press releases or are posted on this website
May 07
Arizona Nutritional Supplements Issues Allergy Alert on Undeclared Soy Allergen in 365 Everyday Value Whey Protein Powder Natural Vanilla Flavor
Food & Beverages
May 07
Natural Way Recalls Almond Butter Due to Undeclared Peanuts
Food & Beverages
May 06
Bloommy, Inc Issues Allergy Alert on Undeclared Fish in Bloommy Biotin Collagen Keratin Capsules
Food & Beverages
FDA VOICES: PERSPECTIVES FROM FDA EXPERTS
FDA Stresses Critical Importance of Safe Disposal of Medications Ahead of National Prescription Drug Take Back Day
For many years, the U.S. Food and Drug Administration has strongly supported work to expand the availability of drug take back programs.
Advancing the Development of Safe and Effective Regenerative Medicine Products
Innovative medical products such as cellular-derived therapies, including stem cell-based products, offer the potential to treat or even cure diseases.
A Year Into the Pandemic: How the FDA’s Center for Devices and Radiological Health is Prioritizing its Workload and Looking Ahead
Since the beginning of the COVID-19 pandemic we have taken steps to attend to the enormous magnitude of COVID-19 related submissions, adopting agile approaches.
Recently Published Guidances
Apr 26
Nonclinical Testing of Individualized Antisense Oligonucleotide Drug Products for Severely Debilitating or Life-Threatening Diseases Guidance for Sponsor-Investigators
Drugs
Apr 23
CVM GFI #188 Data Elements for Submission of Veterinary Adverse Event Reports to the Center for Veterinary Medicine
Animal & Veterinary
Apr 14
Remote Interactive Evaluations of Drug Manufacturing and Bioresearch Monitoring Facilities During the COVID-19 Public Health Emergency Guidance for Industry
Animal & Veterinary, Biologics, Drugs